U.S. Home Infusion Therapy Market Size By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Anti-infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals),

U.S. Home Infusion Therapy Market Size By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Anti-infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals), Industry Analysis Report, Regional Outlook (East North Central {Illinois, Indiana, Michigan, Ohio, Wisconsin}, West South Central {Arkansas, Louisiana, Oklahoma, Texas},South Atlantic {Delaware, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, West Virginia, Washington, D.C}, North East {Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York, Pennsylvania}, East South Central {Alabama, Kentucky, Mississippi, Tennessee}, West North Central {Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, South Dakota}, Pacific Central {Alaska, California, Hawaii, Oregon, Washington}, Mountain States {Arizona, Colorado, Utah, Nevada, New Mexico, Idaho, Montana, Wyoming}), Application Potential & Forecast, 2018 - 2024

U.S. Home Infusion Therapy Market will exceed USD 13.5 billion by 2024; as per a new research report.

Rising prevalence of chronic diseases such as diabetes and cancer will act high impacting factor for growth of U.S. home infusion therapy market. Around 13 million Americans suffer from chronic diseases, requiring special care and continuous administration of fluids to maintain health, thereby fueling demand for home infusion therapy.

Occurrence of chronic diseases is frequent among geriatric population as compared to the young adults. Elderly people generally prefer home infusion therapy due to its ease in operation and convenience associated with its use. Increasing number of surgical procedures dependent on external supply of nutrition will positively influence adoption of home infusion therapy.

Technological advancements pertaining to home infusion pump has accelerated adoption rate of home infusion therapy. For instance, integration of advanced technology in infusion pumps have reduced the level of errors while administering fluids into the patient’s body. However, Improper reimbursement scenario has negatively affected the market growth by reducing the demand for home infusion therapies. Although, affordability issues have been resolved by some American medical insurance companies that will help in increasing the demand for home infusion therapy services over the forecast period.

Infusion pump business segment dominated the U.S. home infusion therapy market in 2017 and is expected to grow significantly over the forecast period. The growth of the segment is accounted to technological developments in the device leading to reduction in errors that otherwise occurred while using the conventional pumps.

Anti-infectives business segment accounted to largest share in 2017 owing to increasing prevalence of skin infections such as candidemia, generating significant demand for anti-infectives therapy. American associations such as National Home Infusion Association (NHIA) are focusing on implementing strategic decisions to develop the schemes for home infusion that have resolved the affordability issues of geriatric population will further propel industry growth.

South Atlantic home infusion therapy market will grow due to growing geriatric population, prone to suffering from infections due to reduced immunity. Elderly people generally suffer hospital acquired infections as well as other bacterial and viral infections that require subsequent treatments. Moreover, growing preference for home infusion therapies has increased due to ease and convenience of receiving the treatment at home will further propel industry growth.

Pacific Central home infusion therapy market growth will show considerable growth rate owing to an increase in number of home infusion therapy pharmacies. Increasing prevalence of diseases coupled with growing geriatric population has increased the demand for home infusion therapies in the region.

Some of the major industry players competing in U.S. home infusion therapy market are Amsino International, Baxter International, B.Braun Melsungen AG, Becton Dickinson, Caesarea Medical Electronics, Fresenius Kabi, Halyard Health, ICU Medical, Moog, Smiths Medical, and Terumo Corporation.

Industry players are adopting various strategic initiatives such as collaboration, partnership, merger and acquisition for sustaining competition as well as gain significant market share. In March 2014, Caesarea Medical Electronics entered into a collaboration with CareFusion, a global medical technology company, to expand its infusion product portfolio. The collaboration with CareFusion aimed at expanding company’s presence across diverse countries in the world.


Report Content
Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. U.S. Home Infusion Therapy industry 360 degree synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Application trends
2.1.4. Regional trends
Chapter 3. U.S. Home Infusion Therapy Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Growing hospital acquired infections
3.3.1.2. Rising prevalence of chronic diseases
3.3.1.3. Advancements in technology
3.3.1.4. Growing geriatric population
3.3.1.5. Presence of homecare facilities
3.3.2. Industry pitfalls & challenges
3.3.2.1. Dearth of reimbursement
3.4. Growth potential analysis
3.4.1. By product
3.4.2. By application
3.5. Regulatory landscape
3.6. Porter's analysis
3.7. Competitive landscape, 2017
3.7.1. Strategy dashboard
3.8. PESTEL analysis
Chapter 4. U.S. Home Infusion Therapy Market, By Product
4.1. U.S. Home Infusion Therapy market share, by product, 2017 & 2024
4.2. Infusion pumps
4.2.1. Market estimates and forecast, by region, 2013 - 2024
4.3. Intravenous sets
4.3.1. Market estimates and forecast, by region, 2013 - 2024
4.4. IV cannulas
4.4.1. Market estimates and forecast, by region, 2013 - 2024
4.5. Needleless connectors
4.5.1. Market estimates and forecast, by region, 2013 - 2024
Chapter 5. U.S. Home Infusion Therapy Market, By Application
5.1. U.S. Home Infusion Therapy market share, by application, 2017 & 2024
5.2. Anti-infectives
5.2.1. Market estimates and forecast, by region, 2013 - 2024
5.3. Hydration therapy
5.3.1. Market estimates and forecast, by region, 2013 - 2024
5.4. Chemotherapy
5.4.1. Market estimates and forecast, by region, 2013 - 2024
5.5. Enteral nutrition
5.5.1. Market estimates and forecast, by region, 2013 - 2024
5.6. Parenteral nutrition
5.6.1. Market estimates and forecast, by region, 2013 - 2024
5.7. Specialty pharmaceuticals
5.7.1. Market estimates and forecast, by region, 2013 - 2024
5.8. Others
5.8.1. Market estimates and forecast, by region, 2013 - 2024
Chapter 6. U.S. Home Infusion Therapy Market, By Region
6.1. U.S. Home Infusion Therapy market share, by region, 2017 & 2024
6.2. East North Central
6.2.1. Market estimates and forecast by state, 2013 - 2024
6.2.2. Market estimates and forecast by product, 2013 - 2024
6.2.3. Market estimates and forecast by application, 2013 - 2024
6.2.4. Illinois
6.2.4.1. Market estimates and forecast by product, 2013 - 2024
6.2.4.2. Market estimates and forecast by application, 2013 - 2024
6.2.5. Indiana
6.2.5.1. Market estimates and forecast by product, 2013 - 2024
6.2.5.2. Market estimates and forecast by application, 2013 - 2024
6.2.6. Michigan
6.2.6.1. Market estimates and forecast by product, 2013 - 2024
6.2.6.2. Market estimates and forecast by application, 2013 - 2024
6.2.7. Ohio
6.2.7.1. Market estimates and forecast by product, 2013 - 2024
6.2.7.2. Market estimates and forecast by application, 2013 - 2024
6.2.8. Wisconsin
6.2.8.1. Market estimates and forecast by product, 2013 - 2024
6.2.8.2. Market estimates and forecast by application, 2013 - 2024
6.3. West South Central
6.3.1. Market estimates and forecast by state, 2013 - 2024
6.3.2. Market estimates and forecast by product, 2013 - 2024
6.3.3. Market estimates and forecast by application, 2013 - 2024
6.3.4. Arkansas
6.3.4.1. Market estimates and forecast by product, 2013 - 2024
6.3.4.2. Market estimates and forecast by application, 2013 - 2024
6.3.5. Louisiana
6.3.5.1. Market estimates and forecast by product, 2013 - 2024
6.3.5.2. Market estimates and forecast by application, 2013 - 2024
6.3.6. Oklahoma
6.3.6.1. Market estimates and forecast by product, 2013 - 2024
6.3.6.2. Market estimates and forecast by application, 2013 - 2024
6.3.7. Texas
6.3.7.1. Market estimates and forecast by product, 2013 - 2024
6.3.7.2. Market estimates and forecast by application, 2013 - 2024
6.4. South Atlantic
6.4.1. Market estimates and forecast by state, 2013 - 2024
6.4.2. Market estimates and forecast by product, 2013 - 2024
6.4.3. Market estimates and forecast by application, 2013 - 2024
6.4.4. Delaware
6.4.4.1. Market estimates and forecast by product, 2013 - 2024
6.4.4.2. Market estimates and forecast by application, 2013 - 2024
6.4.5. Georgia
6.4.5.1. Market estimates and forecast by product, 2013 - 2024
6.4.5.2. Market estimates and forecast by application, 2013 - 2024
6.4.6. Maryland
6.4.6.1. Market estimates and forecast by product, 2013 - 2024
6.4.6.2. Market estimates and forecast by application, 2013 - 2024
6.4.7. North Carolina
6.4.7.1. Market estimates and forecast by product, 2013 - 2024
6.4.7.2. Market estimates and forecast by application, 2013 - 2024
6.4.8. South Carolina
6.4.8.1. Market estimates and forecast by product, 2013 - 2024
6.4.8.2. Market estimates and forecast by application, 2013 - 2024
6.4.9. Virginia
6.4.9.1. Market estimates and forecast by product, 2013 - 2024
6.4.9.2. Market estimates and forecast by application, 2013 - 2024
6.4.10. West Virginia
6.4.10.1. Market estimates and forecast by product, 2013 - 2024
6.4.10.2. Market estimates and forecast by application, 2013 - 2024
6.4.11. Washington D.C.
6.4.11.1. Market estimates and forecast by product, 2013 - 2024
6.4.11.2. Market estimates and forecast by application, 2013 - 2024
6.5. North East
6.5.1. Market estimates and forecast by state, 2013 - 2024
6.5.2. Market estimates and forecast by product, 2013 - 2024
6.5.3. Market estimates and forecast by application, 2013 - 2024
6.5.4. Connecticut
6.5.4.1. Market estimates and forecast by product, 2013 - 2024
6.5.4.2. Market estimates and forecast by application, 2013 - 2024
6.5.5. Maine
6.5.5.1. Market estimates and forecast by product, 2013 - 2024
6.5.5.2. Market estimates and forecast by application, 2013 - 2024
6.5.6. Massachusetts
6.5.6.1. Market estimates and forecast by product, 2013 - 2024
6.5.6.2. Market estimates and forecast by application, 2013 - 2024
6.5.7. New Hampshire
6.5.7.1. Market estimates and forecast by product, 2013 - 2024
6.5.7.2. Market estimates and forecast by application, 2013 - 2024
6.5.8. Rhode Islands
6.5.8.1. Market estimates and forecast by product, 2013 - 2024
6.5.8.2. Market estimates and forecast by application, 2013 - 2024
6.5.9. Vermont
6.5.9.1. Market estimates and forecast by product, 2013 - 2024
6.5.9.2. Market estimates and forecast by application, 2013 - 2024
6.5.10. New Jersey
6.5.10.1. Market estimates and forecast by product, 2013 - 2024
6.5.10.2. Market estimates and forecast by application, 2013 - 2024
6.5.11. New York
6.5.11.1. Market estimates and forecast by product, 2013 - 2024
6.5.11.2. Market estimates and forecast by application, 2013 - 2024
6.5.12. Pennsylvania
6.5.12.1. Market estimates and forecast by product, 2013 - 2024
6.5.12.2. Market estimates and forecast by application, 2013 - 2024
6.6. East South Central
6.6.1. Market estimates and forecast by state, 2013 - 2024
6.6.2. Market estimates and forecast by product, 2013 - 2024
6.6.3. Market estimates and forecast by application, 2013 - 2024
6.6.4. Alabama
6.6.4.1. Market estimates and forecast by product, 2013 - 2024
6.6.4.2. Market estimates and forecast by application, 2013 - 2024
6.6.5. Kentucky
6.6.5.1. Market estimates and forecast by product, 2013 - 2024
6.6.5.2. Market estimates and forecast by application, 2013 - 2024
6.6.6. Mississippi
6.6.6.1. Market estimates and forecast by product, 2013 - 2024
6.6.6.2. Market estimates and forecast by application, 2013 - 2024
6.6.7. Tennessee
6.6.7.1. Market estimates and forecast by product, 2013 - 2024
6.6.7.2. Market estimates and forecast by application, 2013 - 2024
6.7. West North Central
6.7.1. Market estimates and forecast by state, 2013 - 2024
6.7.2. Market estimates and forecast by product, 2013 - 2024
6.7.3. Market estimates and forecast by application, 2013 - 2024
6.7.4. Iowa
6.7.4.1. Market estimates and forecast by product, 2013 - 2024
6.7.4.2. Market estimates and forecast by application, 2013 - 2024
6.7.5. Kansas
6.7.5.1. Market estimates and forecast by product, 2013 - 2024
6.7.5.2. Market estimates and forecast by application, 2013 - 2024
6.7.6. Minnesota
6.7.6.1. Market estimates and forecast by product, 2013 - 2024
6.7.6.2. Market estimates and forecast by application, 2013 - 2024
6.7.7. Missouri
6.7.7.1. Market estimates and forecast by product, 2013 - 2024
6.7.7.2. Market estimates and forecast by application, 2013 - 2024
6.7.8. Nebraska
6.7.8.1. Market estimates and forecast by product, 2013 - 2024
6.7.8.2. Market estimates and forecast by application, 2013 - 2024
6.7.9. North Dakota
6.7.9.1. Market estimates and forecast by product, 2013 - 2024
6.7.9.2. Market estimates and forecast by application, 2013 - 2024
6.7.10. South Dakota
6.7.10.1. Market estimates and forecast by product, 2013 - 2024
6.7.10.2. Market estimates and forecast by application, 2013 - 2024
6.8. Pacific Central
6.8.1. Market estimates and forecast by state, 2013 - 2024
6.8.2. Market estimates and forecast by product, 2013 - 2024
6.8.3. Market estimates and forecast by application, 2013 - 2024
6.8.4. Alaska
6.8.4.1. Market estimates and forecast by product, 2013 - 2024
6.8.4.2. Market estimates and forecast by application, 2013 - 2024
6.8.5. California
6.8.5.1. Market estimates and forecast by product, 2013 - 2024
6.8.5.2. Market estimates and forecast by application, 2013 - 2024
6.8.6. Hawaii
6.8.6.1. Market estimates and forecast by product, 2013 - 2024
6.8.6.2. Market estimates and forecast by application, 2013 - 2024
6.8.7. Oregon
6.8.7.1. Market estimates and forecast by product, 2013 - 2024
6.8.7.2. Market estimates and forecast by application, 2013 - 2024
6.8.8. Washington
6.8.8.1. Market estimates and forecast by product, 2013 - 2024
6.8.8.2. Market estimates and forecast by application, 2013 - 2024
6.9. Mountain States
6.9.1. Market estimates and forecast by state, 2013 - 2024
6.9.2. Market estimates and forecast by product, 2013 - 2024
6.9.3. Market estimates and forecast by application, 2013 - 2024
6.9.4. Arizona
6.9.4.1. Market estimates and forecast by product, 2013 - 2024
6.9.4.2. Market estimates and forecast by application, 2013 - 2024
6.9.5. Colorado
6.9.5.1. Market estimates and forecast by product, 2013 - 2024
6.9.5.2. Market estimates and forecast by application, 2013 - 2024
6.9.6. Utah
6.9.6.1. Market estimates and forecast by product, 2013 - 2024
6.9.6.2. Market estimates and forecast by application, 2013 - 2024
6.9.7. Nevada
6.9.7.1. Market estimates and forecast by product, 2013 - 2024
6.9.7.2. Market estimates and forecast by application, 2013 - 2024
6.9.8. New Mexico
6.9.8.1. Market estimates and forecast by product, 2013 - 2024
6.9.8.2. Market estimates and forecast by application, 2013 - 2024
6.9.9. Idaho
6.9.9.1. Market estimates and forecast by product, 2013 - 2024
6.9.9.2. Market estimates and forecast by application, 2013 - 2024
6.9.10. Montana
6.9.10.1. Market estimates and forecast by product, 2013 - 2024
6.9.10.2. Market estimates and forecast by application, 2013 - 2024
6.9.11. Wyoming
6.9.11.1. Market estimates and forecast by product, 2013 - 2024
6.9.11.2. Market estimates and forecast by application, 2013 - 2024
Chapter 7. Company Profiles
7.1. Amsino International, Inc
7.1.1. Business overview
7.1.2. Financial data
7.1.3. Product landscape
7.1.4. Strategic outlook
7.1.5. SWOT analysis
7.2. Baxter International, Inc
7.2.1. Business overview
7.2.2. Financial data
7.2.3. Product landscape
7.2.4. Strategic outlook
7.2.5. SWOT analysis
7.3. B.Braun Melsungen AG
7.3.1. Business overview
7.3.2. Financial data
7.3.3. Product landscape
7.3.4. Strategic outlook
7.3.5. SWOT analysis
7.4. Becton Dickinson
7.4.1. Business overview
7.4.2. Financial data
7.4.3. Product landscape
7.4.4. Strategic outlook
7.4.5. SWOT analysis
7.5. Caesarea Medical Electronics
7.5.1. Business overview
7.5.2. Financial data
7.5.3. Product landscape
7.5.4. Strategic outlook
7.5.5. SWOT analysis
7.6. Fresenius Kabi
7.6.1. Business overview
7.6.2. Financial data
7.6.3. Product landscape
7.6.4. Strategic outlook
7.6.5. SWOT analysis
7.7. Halyard Health, Inc
7.7.1. Business overview
7.7.2. Financial data
7.7.3. Product landscape
7.7.4. Strategic outlook
7.7.5. SWOT analysis
7.8. ICU Medical Inc
7.8.1. Business overview
7.8.2. Financial data
7.8.3. Product landscape
7.8.4. Strategic outlook
7.8.5. SWOT analysis
7.9. Moog Inc
7.9.1. Business overview
7.9.2. Financial data
7.9.3. Product landscape
7.9.4. Strategic outlook
7.9.5. SWOT analysis
7.10. Smiths Medical
7.10.1. Business overview
7.10.2. Financial data
7.10.3. Product landscape
7.10.4. Strategic outlook
7.10.5. SWOT analysis
7.11. Terumo Corporation
7.11.1. Business overview
7.11.2. Financial data
7.11.3. Product landscape
7.11.4. Strategic outlook
7.11.5. SWOT analysis
Data Tables
TABLE 1. U.S. home infusion therapy industry 360 degree synopsis, 2013 - 2024
TABLE 2. U.S. home infusion therapy market size, 2013-2024 (USD Million)
TABLE 3. U.S. home infusion therapy market size, by product, 2013-2024 (USD Million)
TABLE 4. U.S. home infusion therapy market size, by application, 2013-2024 (USD Million)
TABLE 5. U.S. home infusion therapy market size, by state, 2013-2024 (USD Million)
TABLE 6. Industry impact forces
TABLE 7. Infusion pumps estimates and forecast, by state, 2013 - 2024 (USD Million)
TABLE 8. Intravenous sets market size, by state, 2013 - 2024 (USD Million)
TABLE 9. IV cannulas market size, by state, 2013 - 2024 (USD Million)
TABLE 10. Needleless connectors market size, by state, 2013 - 2024 (USD Million)
TABLE 11. Anti-infective estimates and forecast, by state, 2013 - 2024 (USD Million)
TABLE 12. Hydration therapy market size, by state, 2013 - 2024 (USD Million)
TABLE 13. Chemotherapy market size, by state, 2013 - 2024 (USD Million)
TABLE 14. Enteral nutrition market size, by state, 2013 - 2024 (USD Million)
TABLE 15. Parenteral nutrition market size, by state, 2013 - 2024 (USD Million)
TABLE 16. Specialty pharmaceuticals market size, by state, 2013 - 2024 (USD Million)
TABLE 17. Others market size, by state, 2013 - 2024 (USD Million)
TABLE 18. Regional Homecare Consumer Profile
TABLE 19. East North Central home infusion therapy market size, 2013-2024 (USD Million)
TABLE 20. East North Central home infusion therapy market size, by product, 2013-2024, (USD Mn)
TABLE 21. East North Central home infusion therapy market size, by application, 2013-2024, (USD Mn)
TABLE 22. Illinois home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 23. Illinois home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 24. Indiana home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 25. Indiana home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 26. Michigan home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 27. Michigan home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 28. Ohio home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 29. Ohio home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 30. Wisconsin home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 31. Wisconsin home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 32. Regional Homecare Consumer Profile
TABLE 33. West South-Central home infusion therapy market size, by state, 2013 - 2024 (USD Million)
TABLE 34. West South-Central home infusion therapy market size, by product, 2013 - 2024, (USD Mn)
TABLE 35. West South-Central home infusion therapy market, by application, 2013-2024, (USD Million)
TABLE 36. Arkansas home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 37. Arkansas home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 38. Louisiana home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 39. Louisiana home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 40. Oklahoma home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 41. Oklahoma home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 42. Texas home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 43. Texas home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 44. Regional Homecare Consumer Profile
TABLE 45. South Atlantic home infusion therapy market size, 2013 - 2024 (USD Million)
TABLE 46. South Atlantic home infusion therapy market size, by product, 2013 - 2024, (USD Million)
TABLE 47. South Atlantic home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 48. Delaware home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 49. Delaware home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 50. Florida home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 51. Florida home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 52. Georgia home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 53. Georgia home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 54. Maryland home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 55. Maryland home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 56. North Carolina home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 57. North Carolina home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 58. South Carolina home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 59. South Carolina home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 60. Virginia home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 61. Virginia home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 62. West Virginia home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 63. West Virginia home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 64. Washington, D.C. home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 65. Washington, D.C. home infusion therapy market size, by application, 2013-2024, (USD Mn)
TABLE 66. Regional Homecare Consumer Profile
TABLE 67. North East home infusion therapy market size, 2013 - 2024 (USD Million)
TABLE 68. North East home infusion therapy market size, by product, 2013 - 2024, (USD Million)
TABLE 69. North East home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 70. Connecticut home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 71. Connecticut home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 72. Maine home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 73. Maine home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 74. Massachusetts home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 75. Massachusetts home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 76. New Hampshire home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 77. New Hampshire home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 78. Rhode Island home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 79. Rhode Island home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 80. Vermont home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 81. Vermont home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 82. New Jersey home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 83. New Jersey home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 84. New York home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 85. New York home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 86. Pennsylvania home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 87. Pennsylvania home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 88. Regional Homecare Consumer Profile
TABLE 89. East South-Central home infusion therapy market size, 2013 - 2024 (USD Million)
TABLE 90. East South-Central home infusion therapy market size, by product, 2013 - 2024, (USD Million)
TABLE 91. East South-Central home infusion therapy market size, by application, 2013-2024, (USD Mn)
TABLE 92. Alabama home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 93. Alabama home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 94. Kentucky home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 95. Kentucky home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 96. Mississippi home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 97. Mississippi home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 98. Tennessee home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 99. Tennessee home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 100. Regional Homecare Consumer Profile
TABLE 101. West North Central home infusion therapy market size, 2013 - 2024 (USD Million)
TABLE 102. West North Central home infusion therapy market size, by product, 2013 - 2024, (USD Mn)
TABLE 103. West North Central home infusion therapy market size, by application, 2013-2024, (USD Mn)
TABLE 104. Iowa home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 105. Iowa home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 106. Kansas home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 107. Kansas home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 108. Minnesota home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 109. Minnesota home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 110. Missouri home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 111. Missouri home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 112. Nebraska home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 113. Nebraska home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 114. North Dakota home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 115. North Dakota home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 116. South Dakota home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 117. South Dakota home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 118. Regional Homecare Consumer Profile
TABLE 119. Pacific Central home infusion therapy market size, 2013 - 2024 (USD Million)
TABLE 120. Pacific Central home infusion therapy market size, by product, 2013 - 2024, (USD Million)
TABLE 121. Pacific Central home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 122. Alaska home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 123. Alaska home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 124. California home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 125. California home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 126. Hawaii home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 127. Hawaii home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 128. Oregon home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 129. Oregon home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 130. Washington home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 131. Washington home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 132. Regional Homecare Consumer Profile
TABLE 133. Mountain States home infusion therapy market size, 2013 - 2024 (USD Million)
TABLE 134. Mountain States home infusion therapy market size, by product, 2013 - 2024, (USD Million)
TABLE 135. Mountain States home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 136. Arizona home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 137. Arizona home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 138. Colorado home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 139. Colorado home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 140. Utah home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 141. Utah home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 142. Nevada home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 143. Nevada home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 144. New Mexico home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 145. New Mexico home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 146. Idaho home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 147. Idaho home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 148. Montana home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 149. Montana home infusion therapy market size, by application, 2013-2024, (USD Million)
TABLE 150. Wyoming home infusion therapy market size, by product, 2013-2024, (USD Million)
TABLE 151. Wyoming home infusion therapy market size, by application, 2013-2024, (USD Million)
Charts & Figures
FIG. 1 Industry segmentation
FIG. 2 U.S. home infusion therapy market, 2013 - 2024 (USD Million)
FIG. 3 Cost associated with hospital acquired infections in U.S.
FIG. 4 Cost of cancer among U.S. states (USD Million)
FIG. 5 Cost of cardiovascular disease among U.S. states (USD Million)
FIG. 6 Cost of diabetes among U.S. states (USD Million)
FIG. 7 Estimates and forecast for U.S. geriatric population (In thousands)
FIG. 8 Growth potential analysis, by product
FIG. 9 Growth potential analysis, by application
FIG. 10 Porter's analysis
FIG. 11 Strategy dashboard
FIG. 12 PESTEL analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook